Ming-Fong Lin Selected Research

prostatic acid phosphatase

10/2021	Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis.
10/2021	Multifunctionality of Prostatic Acid Phosphatase in Prostate Cancer Pathogenesis.
1/2015	Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression.
8/2014	Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.
7/2010	Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth.
12/2005	Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer.
10/2005	Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells.
6/2003	Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
2/2003	ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Fong Lin Research Topics

Disease

61	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 03/2002
34	Neoplasms (Cancer) 10/2021 - 01/2003
10	Carcinoma (Carcinomatosis) 01/2011 - 10/2003
6	Carcinogenesis 08/2014 - 02/2004
6	Neoplasm Metastasis (Metastasis) 06/2011 - 11/2003
2	Ovarian Neoplasms (Ovarian Cancer) 08/2015 - 01/2011
2	Adenocarcinoma 07/2012 - 11/2003
2	Breast Neoplasms (Breast Cancer) 03/2009 - 02/2004
1	Hypercholesterolemia 07/2013
1	Lung Neoplasms (Lung Cancer) 04/2013
1	Body Weight (Weight, Body) 04/2013
1	Hypoxia (Hypoxemia) 04/2013
1	Inflammation (Inflammations) 04/2013
1	Pain (Aches) 12/2011
1	Dysuria 12/2011
1	Lower Urinary Tract Symptoms 12/2011
1	Cystitis 12/2011

Drug/Important Bio-Agent (IBA)

42	AndrogensIBA 11/2018 - 03/2002
16	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2002
16	Hormones (Hormone)IBA 09/2012 - 03/2002
15	Androgen Receptors (Androgen Receptor)IBA 01/2017 - 04/2004
9	prostatic acid phosphataseIBA 10/2021 - 02/2003
8	Biomarkers (Surrogate Marker)IBA 11/2017 - 12/2005
7	SteroidsIBA 05/2021 - 02/2004
6	Tyrosine (L-Tyrosine)FDA Link 07/2012 - 02/2003
5	Protein Tyrosine PhosphatasesIBA 05/2013 - 02/2003
4	Docetaxel (Taxotere)FDA Link 11/2018 - 11/2003
4	Histone Deacetylase InhibitorsIBA 12/2015 - 07/2011
4	LigandsIBA 06/2014 - 01/2009
4	ErbB Receptors (EGF Receptor)IBA 12/2007 - 02/2006
4	Gefitinib (Iressa)FDA Link 12/2007 - 02/2006
3	Pharmaceutical PreparationsIBA 11/2018 - 02/2006
3	EnzymesIBA 11/2017 - 11/2008
3	CholesterolIBA 12/2016 - 11/2008
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2015 - 07/2011
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2014 - 01/2008
3	CytokinesIBA 04/2013 - 06/2003
3	cyclopamineIBA 12/2007 - 02/2006
3	Prostate-Specific Antigen (Semenogelase)IBA 03/2006 - 06/2003
2	Membrane Proteins (Integral Membrane Proteins)IBA 10/2021 - 10/2021
2	N- (3- phenyl- n- propyl)- 1- phenyl- 2- aminopropane (PPAP)IBA 10/2021 - 10/2021
2	Protein Sorting Signals (Signal Peptide)IBA 10/2021 - 10/2021
2	1- (4- (furo(2,3- b)quinolin- 4- ylamino)phenyl)ethanoneIBA 11/2018 - 01/2015
2	Mannose (D-Mannose)IBA 11/2017 - 03/2003
2	GlycosyltransferasesIBA 11/2017 - 06/2011
2	Androgen Antagonists (Antiandrogens)IBA 01/2017 - 02/2004
2	bicalutamide (Casodex)FDA LinkGeneric 01/2017 - 02/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 12/2016
2	human ERBB2 proteinIBA 11/2015 - 12/2005
2	imidazopyridineIBA 01/2015 - 10/2014
2	PhosphotyrosineIBA 05/2013 - 12/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2013 - 01/2004
2	LactoferrinIBA 04/2013 - 06/2010
2	Epidermal Growth Factor (EGF)IBA 12/2007 - 03/2007
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2007 - 12/2005
2	ElementsIBA 03/2007 - 01/2004
2	Tyrosine Kinase InhibitorsIBA 01/2007 - 02/2006
1	Polysaccharides (Glycans)IBA 11/2017
1	MannosidasesIBA 11/2017
1	macrogolginIBA 11/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2017
1	Cyproterone AcetateIBA 01/2017
1	Abiraterone AcetateIBA 01/2017
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2017
1	Simvastatin (Zocor)FDA LinkGeneric 12/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2015
1	Anticarcinogenic AgentsIBA 02/2015
1	quinolineIBA 01/2015
1	Antimitotic AgentsIBA 01/2015
1	Dihydrotestosterone (Androstanolone)IBA 06/2014
1	Cholecalciferol (Vitamin D3)FDA Link 01/2014
1	Phenobarbital (Luminal)FDA Link 01/2014
1	SterolsIBA 07/2013
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 07/2013
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2013
1	Dimethylallyltranstransferase (Dimethylallyltransferase)IBA 07/2013
1	VitaminsIBA 07/2013
1	Interleukin-10 (Interleukin 10)IBA 04/2013
1	Interleukin-4 (Interleukin 4)IBA 04/2013
1	Therapeutic UsesIBA 04/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2013
1	Interleukin-6 (Interleukin 6)IBA 04/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2012
1	hydrogen sulfite (bisulfite)IBA 04/2012
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2012
1	Decitabine FDA Link 04/2012
1	GTP-Binding Proteins (G-Protein)IBA 04/2012
1	Valproic Acid (Depakote)FDA LinkGeneric 12/2011
1	Ketamine FDA LinkGeneric 12/2011
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2011
1	Mitogen-Activated Protein Kinase 3IBA 11/2011
1	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2011

Therapy/Procedure

17	Therapeutics 01/2019 - 02/2003
15	Castration 01/2021 - 06/2011
1	Ligation 11/2017
1	Lasers (Laser) 11/2017
1	Drug Therapy (Chemotherapy) 12/2015
1	Chemoprevention 04/2013
1	Oral Administration 04/2013